KR20010044542A - Health auxiliary food composition having effect for intestines function and food comprising same - Google Patents
Health auxiliary food composition having effect for intestines function and food comprising same Download PDFInfo
- Publication number
- KR20010044542A KR20010044542A KR1020010011275A KR20010011275A KR20010044542A KR 20010044542 A KR20010044542 A KR 20010044542A KR 1020010011275 A KR1020010011275 A KR 1020010011275A KR 20010011275 A KR20010011275 A KR 20010011275A KR 20010044542 A KR20010044542 A KR 20010044542A
- Authority
- KR
- South Korea
- Prior art keywords
- food
- dietary supplement
- supplement composition
- effect
- senna
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 230000000694 effects Effects 0.000 title claims abstract description 28
- 230000036541 health Effects 0.000 title abstract description 6
- 210000000936 intestine Anatomy 0.000 title abstract description 6
- 229940076742 senna leaves Drugs 0.000 claims abstract description 15
- 235000009508 confectionery Nutrition 0.000 claims abstract description 13
- 235000015872 dietary supplement Nutrition 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 13
- 230000003213 activating effect Effects 0.000 claims description 9
- 235000013616 tea Nutrition 0.000 claims description 8
- 230000000968 intestinal effect Effects 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 4
- 230000035622 drinking Effects 0.000 claims description 3
- 235000013324 preserved food Nutrition 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000013365 dairy product Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims 1
- 244000075850 Avena orientalis Species 0.000 claims 1
- 238000003287 bathing Methods 0.000 claims 1
- 235000005911 diet Nutrition 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 3
- IPQVTOJGNYVQEO-CXZNLNCXSA-N sennoside A Natural products O=C(O)c1cc(O)c2C(=O)c3c(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O4)cccc3[C@@H]([C@H]3c4c(c(O)cc(C(=O)O)c4)C(=O)c4c(O[C@H]5[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O5)cccc34)c2c1 IPQVTOJGNYVQEO-CXZNLNCXSA-N 0.000 abstract 4
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 abstract 2
- IPQVTOJGNYVQEO-AIFLABODSA-N sennoside B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-AIFLABODSA-N 0.000 abstract 2
- 241000604742 Machilus thunbergii Species 0.000 abstract 1
- 235000004267 Persea thunbergii Nutrition 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 description 23
- 241001249696 Senna alexandrina Species 0.000 description 16
- 235000006693 Cassia laevigata Nutrition 0.000 description 14
- 229940124513 senna glycoside Drugs 0.000 description 14
- 239000002994 raw material Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 244000269722 Thea sinensis Species 0.000 description 8
- 230000003871 intestinal function Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000024330 bloating Diseases 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- -1 naphthalene glucoside Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001116389 Aloe Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- OZFQHULMMDWMIV-UHFFFAOYSA-N Rheinanthrone Chemical compound C1=CC=C2CC3=CC(C(=O)O)=CC(O)=C3C(=O)C2=C1O OZFQHULMMDWMIV-UHFFFAOYSA-N 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 208000007645 potassium deficiency Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- IPQVTOJGNYVQEO-JLDSCGAUSA-N sennoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1C2C1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-JLDSCGAUSA-N 0.000 description 1
- 239000009814 sennoside A&B Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 장기능 활성효과를 갖는 건강 보조 식품 조성물 및 이를 포함하는 식품에 관한 것으로, 좀 더 상세하게는 센나(senna)엽 또는 세노사이드(sennoside) A & B를 포함하는 건강 보조 식품 조성물 및 이를 포함하는 식품에 관한 것이다.The present invention relates to a dietary supplement composition having an intestinal activating effect and a food comprising the same, and more particularly, to a dietary supplement composition comprising senna leaf or sennoside A & B and the same. It relates to the food containing.
산업이 발달하고 빠르게 근대화되어감에 따라 현대인의 식생활은 서구화되어 가고 이러한 식생활 패턴의 변화로 인하여 인체의 신진대사에 부조화를 초래하게 되었다. 이러한 문제로 고칼로리 식품, 인스턴트 식품 및 고지방 식품 등의 섭취가 증가하고 섬유소 등의 섭취가 감소하며, 또한 편한 생활을 추구하는 생활습관에 의해 운동부족 현상이 일어나, 현대인에게는 변비, 변취 또는 비만이 큰 문제가 되고 있다.As the industry developed and rapidly modernized, the dietary life of modern man became westernized, and the change of dietary patterns caused disharmony in the metabolism of the human body. Due to these problems, the intake of high-calorie foods, instant foods and high-fat foods increases, the intake of fiber, etc. decreases, and the lack of exercise is caused by a lifestyle that promotes a comfortable life. It is a big problem.
이러한 문제를 해결하기 위해 다양한 방법들이 연구되어 오고 있으며, 그 결과로서 다양한 의약품 또는 식품 등이 개발되어 오고 있다. 예를 들어, 상기 변비 등의 문제를 해결하기 위해서 장기능의 활성을 최우선으로 볼 수 있는데, 이를 위한 많은 연구가 실시되었다.Various methods have been studied to solve this problem, and as a result, various medicines or foods have been developed. For example, in order to solve the problems such as constipation can be seen as the priority of the activity of the intestinal function, many studies have been carried out for this.
예를 들어, 한국특허공고 제180452호에는 변비 및 변취 개선효과를 갖는 건강 영양 조성물로서, 알로에 아보레센스 분말에 동규자와 삼백초의 유효성분을 알코올로 추출한 엑기스 또는 그 분말을 주성분으로 하고 여기에 녹차의 유효성분을 추출한 엑기스 또는 그 분말을 배합하여 이루어진 건강 영양 조성물이 기재되어 있다.For example, Korean Patent Publication No. 180452 discloses a health nutrition composition having an effect of improving constipation and odor, wherein the aloe vera essence powder contains extracts of copper and three hundred s of the active ingredient as alcohols, or a powder thereof. The health nutrition composition which mix | blended the extract which extracted the effective ingredient or its powder is described.
그 외에도 한국 공개특허공보 제99-84271호에는 동규자, 동규자엽, 결정자, 결명자엽, 노회, 대황, 망초, 센나엽, 마자인, 감수, 대극, 원화, 파두, 흑축 등으로 이루어진 군으로부터 1종 이상 혼합하여 제조한 차(茶)가 기재되어 있으며, 한국특허공고 제149389호에는 말린귤껍질, 인삼, 오미자, 백반, 감초, 살구씨, 및 구기자를 이용한 변비치료용 생약성분 조성물이 기재되어 있다.In addition, Korean Laid-Open Patent Publication No. 99-84271 discloses one species from the group consisting of Donggyuja, Donggyu cotyledon, crystallization, cotyledopia cotyledons, presbytery, rhubarb, forget-me-not, Senna yeop, mazain, supervised, Daegu, Wonhwa, Padu, and black shaft. A tea prepared by mixing the above is described, and Korean Patent Publication No. 149389 describes a herbal composition for treating constipation using dried tangerine peel, ginseng, Schisandra chinensis, alum, licorice, apricot seed, and wolfberry. .
이와 같이, 천연식물을 이용하여 변비를 해결하고자 하는 많은 연구가 진행되어 왔는데, 특히 센나엽은 장기능 활성에 특효가 있는 것으로 알려져 있다. 상기 센나엽의 학명은 cassia augustifolia, cassia acutifolia delile 등으로 알려져 있으며 잎을 가진 콩과 식물 관목으로 사막지역에서 야생으로 자라거나 근래에 들어서는 다량 경작되고 있다. 동서양에 공통적으로 센나엽은 변비의 해결을 위해 사용하는 대체 완하제로서 주로 의약품에 사용되고 있다. 예를 들어 미국특허 제4,595,592호에는 센나 약제로부터 변비치료제를 얻는 방법이 기재되어 있다.As such, many studies have been conducted to solve constipation using natural plants, in particular, senna leaves are known to be effective in intestinal function. The scientific name of the senna leaf is known as cassia augustifolia, cassia acutifolia delile, etc. and is a leafy legume shrub that is grown in the wild in the desert or recently cultivated in large quantities. Common to the East and West, Senna Leaf is an alternative laxative used to resolve constipation. For example, US Pat. No. 4,595,592 describes a method for obtaining constipation therapy from Senna drugs.
상기 센나엽과 함께 의약품에 많이 사용되고 있는 세노사이드 A & B는 다양한 추출방법을 통해 얻어지는데, 미국특허 제5,574,151호에는 레인안트론-8-글루코사이드(rheinanthrone-8-glucoside)가 산소 또는 산소원에 의해 산화되어 세노사이드 A & B를 제조하는 방법이 기재되어 있으며, 미국특허 제5,397,573호에는 세노사이드 및 약제학적으로 유용한 메탄올, 이들의 혼합물로 이루어진 변비치료 조성물이 기재되어 있고, 또한, 미국특허 제5,232,699호에는 실륨(psyllium) 및 세노사이드를 포함하는 변비치료 조성물이 기재되어 있다. 그외에도 일본 특개평 9-504280호 및 일본 특개평 5-345724에는 세노사이드를 포함하는 약제가 언급되어 있다.Cenosides A & B, which are widely used in medicine with the senna lobe, are obtained through various extraction methods. US Pat. No. 5,574,151 discloses rheinanthrone-8-glucoside as an oxygen or oxygen source. A method of oxidizing to produce cenosides A & B is described, US Pat. No. 5,397,573 describes a constipation therapeutic composition consisting of cenosides and pharmaceutically useful methanol, mixtures thereof, and also US Patent No. 5,232,699 describes a constipation therapeutic composition comprising psyllium and senosides. In addition, Japanese Patent Application Laid-open No. Hei 9-504280 and Japanese Patent Laid-open No. Hei 5-345724 mention a medicament comprising cenoside.
전술한 바와 같이, 장기능 활성에 효과적인 세노사이드는 주로 약제학적으로 의약품으로 다양하게 사용되어 왔으나, 이를 식품의 원료, 부원료 또는 첨가물의 형태로 활용한 방법 또는 구체적 수치는 밝혀진 바 없었다. 또한 종래의 약품에 비해 쉽게 구할 수 있고 안전한 상태로 변비 등의 개선효과를 얻을 수 있는 방법이 계속적으로 연구중에 있다.As mentioned above, cenosides effective for intestinal function activity have been mainly used in various pharmaceutical forms as pharmaceuticals, but no method or specific value thereof has been used in the form of raw materials, subsidiary materials or additives of food. In addition, methods that can be easily obtained compared to the conventional medicine and can be obtained to improve the constipation and the like in a safe state are continuously being studied.
이에 본 발명자들의 계속적인 연구 검토 결과, 장기능 활성 기능을 갖는 센나엽 또는 세노사이드 A & B를 이용하여 건강 보조 식품을 제조할 수 있음을 발견하였으며, 본 발명은 이에 기초하여 완성되었다.Accordingly, as a result of continuous study and review by the present inventors, it has been found that a health supplement can be prepared using Senna lobe or Cenosides A & B having intestinal function active function, and the present invention has been completed based on this.
따라서, 본 발명의 목적은 식생활 습관의 서구화로 인한 신진대사의 저하로 인해 빈번히 발생하는 변비, 변취, 변비성 비만, 만성 비만, 및 소화불량을 해결할 수 있도록 장기능을 활성화시킬 수 있는 물질을 이용함으로써 장운동을 활성화시켜 변비 등을 해결할 수 있고 이로서 다이어트 효과를 얻을 수 있는 건강 보조 식품 조성물을 제공하는데 있다.Accordingly, an object of the present invention is to use a substance capable of activating intestinal function to resolve constipation, odor, constipation obesity, chronic obesity, and indigestion that frequently occur due to the decrease in metabolism due to westernization of dietary habits By activating the bowel movements to solve constipation and the like to provide a dietary supplement composition that can achieve a diet effect.
또한 본 발명의 다른 목적은 상기 장기능 활성효과를 갖는 건강 보조 식품 조성물을 포함하는 식품을 제공하는데 있다.In addition, another object of the present invention to provide a food comprising a dietary supplement composition having the bowel function active effect.
상기 목적을 달성하기 위한 본 발명에 따른 장기능 활성효과를 갖는 건강 보조 식품 조성물은 1회 섭식 용량으로 센나엽 0.25∼3g 또는 세노사이드 A & B 0.8∼52mg를 포함하여 이루어진다.The health supplement composition having an enteric function active effect according to the present invention for achieving the above object comprises 0.25 to 3 g of senena lobe or 0.8 to 52 mg of senoside A & B in a single feeding dose.
또한 다른 목적을 달성하기 위한 본 발명에 따른 건조 식품은 전술한 장기능 활성효과를 갖는 건강 보조 식품 조성물을 포함하여 이루어진다.In addition, the dried food according to the present invention for achieving another object comprises a dietary supplement composition having the above-described bowel function active effect.
또한 상기 또 다른 목적을 달성하기 위한 본 발명에 따른 습윤 식품은 전술한 장기능 활성효과를 갖는 건강 보조 식품 조성물을 포함하여 이루어진다.In addition, the wet food according to the present invention for achieving the above another object comprises a dietary supplement composition having the above-described bowel function active effect.
이하, 본 발명을 좀 더 구체적으로 설명하고자 한다.Hereinafter, the present invention will be described in more detail.
전술한 바와 같이, 본 발명에 따른 건강 보조식품 조성물은 센나엽 또는 세노사이드 A & B를 포함하여 장기능 활성효과를 갖는데, 센나는 cassia angustifolia, cassia acutfolia delile 등의 학명을 가지며, 북부 및 동북부 아프리카가 원산지이고, 현재는 남부 및 북서부 인도와 파키스탄 등지에서 대량으로 경작되고 있으며, 이의 어린잎을 건조하여 사용한다. 특히 센나엽은 변비에 효과가 있다고 알려진 세노사이드 A & B를 자연 상태에서 1.5∼3% 함유하고 있으며, 이외에도 소량의 세노사이드 C & D, 나프탈렌 글루코사이드, 플라노이드 등의 물질도 포함되어 있다.As described above, the dietary supplement composition according to the present invention has an intestinal activating effect, including Senna lobe or Cenosides A & B. Senna has a scientific name such as cassia angustifolia, cassia acutfolia delile, and northern and northeastern Africa. Is native to the country and is currently cultivated in large quantities in southern and northwestern India and Pakistan, and its young leaves are dried and used. In particular, senna leaves contain 1.5% to 3% of cenosides A & B, which are known to be effective for constipation, and other small amounts of substances such as cenosides C & D, naphthalene glucoside, and flanoids.
또한, 상기 세노사이드 A & B로 잘 알려져 있는 하이드록시안트라센 글리코사이드(hydroxyanthracene glycosides)는 하기 화학식 1로 표시되며, 센나엽, 대황, 알로에 및 일부 광물질 등으로부터 추출가능하며, 센나엽에서 가장 많은 양을 추출할 수 있다.In addition, the hydroxyanthracene glycosides well known as the senosides A & B are represented by the following formula (1), extractable from senna leaves, rhubarb, aloe and some minerals, and the highest amount in senna leaves. Can be extracted.
상기 세노사이드 A & B는 인체에 섭취가 되면 대장에서 효소호흡에 의한 환원작용으로 인해 레인안트론(rheinanthrone)으로 불리는 환원성 물질로 분해 전환되어, 이 물질이 대장에서 활발한 대사작용을 함으로써 직접 장의 운동을 돕게 된다. 또한 이 물질은 장에서 빠르게 통과되며 대장에서 흡수되는 액체를 감소시키고, 98% 이상이 대장속의 대변에 섞여 배설된다.When the sernosides A & B are ingested by the human body, they are converted into a reducing substance called rheinanthrone due to enzymatic respiration in the large intestine, and the substance is actively metabolized in the large intestine. Will help. The substance also passes rapidly in the intestine and reduces the liquid absorbed by the large intestine, and more than 98% is excreted in feces in the large intestine.
특히, 상기 세노사이드 A & B는, 특별히 한정되는 것은 아니지만 센나엽으로부터 추출된 것이 바람직하다. 본 발명에 있어서는 센나엽을 분쇄하여 분말을 식품에 첨가하거나, 또는 중탕 또는 침출한 물을 사용함으로서 식품에 첨가하거나, 또는 (침출 방법에 의해) 추출된 세노사이드 A & B를 분말 또는 엑기스의 형태로 첨가하는 것이 바람직하지만, 이에 한정되는 것은 아니다.In particular, the above-mentioned senoside A & B is not particularly limited, but is preferably extracted from senna leaves. In the present invention, senna leaves are pulverized to add powder to the food, or to the food by using a bath or leached water, or the extracted cenosides A & B (by leaching method) in the form of powder or extract. Although it is preferable to add as, it is not limited to this.
이러한 센나엽 또는 세노사이드 A & B는 장에서 활발한 대사작용을 하여 대장에서의 정체를 억제하고 배설을 촉진하여 보편적으로 심한 변비의 치료에 쓰이는 의약품의 재료로 알려져 있다. 또한 몸에 잘 흡수되지 않고 98%이상이 대장속의 대변에 섞여 종합체로 배설된다고 알려져 있다.Senna lobe or Cenosides A & B are active metabolism in the intestine to suppress the congestion in the large intestine and promote the excretion is commonly known as a material of medicine used in the treatment of severe constipation. In addition, it is known that it is not absorbed well by the body and more than 98% is mixed with feces in the large intestine and excreted as a total body.
의약품에 있어서는 심한 변비의 경우, 성인 일인당 일일 복용량을 센나는 3g∼6g정도, 세노사이드는 120mg∼240mg 정도로 규정하고 있으며, 지속적인 복용을 할 때에는 1회 40∼80mg을 매 식후에 복용하도록 하고 있고, 이와 같은 양을 복용하게 되면 용변의 형태가 설사의 수준에 도달하게 되는 것이다.In case of severe constipation, the daily dose per adult is about 3g ~ 6g, and the senoside is about 120mg ~ 240mg, and when taking continuous dose, 40 ~ 80mg is taken after each meal. When you take this amount of stool form will reach the level of diarrhea.
이러한 센나엽 또는 세노사이드 A & B를 좀 더 구체적으로 연구 검토한 결과, 본 발명에 있어서, 상기 세노사이드 A & B가 식품 가공물의 원료나 첨가물로 사용되는 경우 1회 섭식 기준 0.8∼5.2mg의 함량으로 첨가되면 묽은 변상태의 배설을 원활히 하는 우수한 장기능 활성효과를 갖는 건강 보조 식품 조성물을 발견할 수 있었다. 상기 세노사이드 A & B의 함량이 0.8mg 미만으로 첨가되면 얻고자 하는 변비 등의 개선 효과를 얻을 수 없고, 5.2mg을 초과하면 특별히 문제가 되는 것은 아니지만, 지나친 장 운동으로 설사 등을 유발할 수도 있다는 문제를 갖는다.As a result of more detailed research and investigation of such senona leaf or cenoside A & B, in the present invention, when the cenoside A & B is used as a raw material or an additive of a food processed product, 0.8 to 5.2 mg of one feeding standard When added in the content was found a dietary supplement composition having an excellent long-acting activity effect that facilitates the excretion of thin feces. If the content of the senosides A & B is less than 0.8mg, the improvement effect such as constipation to be obtained cannot be obtained, and if it exceeds 5.2mg, there is no particular problem, but excessive diarrhea may cause diarrhea or the like. Have a problem.
또한, 상기 센나엽이 직접 식품 가공물의 원료나 첨가물로 사용되는 경우에는 0.25∼3g의 함량으로 첨가될 수 있으며, 센나엽 역시 함량이 0.25g 미만으로 첨가되면 얻고자 하는 변비 등의 개선 효과를 얻을 수 없고, 3g을 초과하면 상기에서와 같이 지나친 장 운동으로 설사 등을 유발할 수도 있는 문제점을 갖는다.In addition, when the senna leaf is directly used as a raw material or an additive of food processing, it may be added in an amount of 0.25 to 3 g, and when the senna leaf is also added in an amount less than 0.25 g, an improvement effect such as constipation to be obtained is obtained. If it exceeds 3g, there is a problem that may cause diarrhea due to excessive intestinal exercise as described above.
즉, 본 발명을 구성하는 주요 연구는 비약품이면서도 약품에서 나타나는 설사 등의 부작용 방지 기준 물량 이하의 센나엽(0.25∼3g) 또는 세노사이드(0.8∼52mg)를 식품의 부원료, 첨가물, 또는 주원료로 사용하여 유용한 효과를 볼 수 있는 적정량의 범위를 밝혀낸 것이며, 이의 식품으로서의 유용치의 범위를 설정하고 이를 식품의 제조 공정등에 적용시킨 데 있다.That is, the main research constituting the present invention is a non-pharmaceutical, but a senna leaf (0.25 to 3 g) or senoside (0.8 to 52 mg), which is below the standard for preventing side effects such as diarrhea that occurs in the drug, is used as an ingredient, additive, or main ingredient of food. It is to find out the range of the appropriate amount to see the useful effect by using, and to set the range of the useful value as the food and to apply it to the manufacturing process of the food.
이와 같이 센나엽은 식품의 주원료 또는 부원료로도 포함될 수 있다. 주원료로서 사용가능한 경우는 차와 같은 음용차류로서, 티백 등을 이용하여 녹차와 같이 복용할 수 있다. 또한 건조 분말형태로 껌, 과자, 캔디, 빵 등의 식품 부원료로서 첨가되어 사용될 수 있다.As such, the senna leaf may be included as a main raw material or a subsidiary material of food. When it can be used as a main raw material, it can be taken with green tea using a tea bag etc. as a drinking tea like tea. It may also be used in the form of dry powder as food additives such as gum, confectionery, candy, bread and the like.
또한, 상기 센나엽 또는 세노사이드 A & B는 경우에 따라서 장에서 부담을 갖는 경우도 발생할 수 있으나, 본 발명에서는 후박을 세노사이드 A & B의 1일 섭취량의 절반 정도인 0.4∼26mg으로 함께 섭취할 수 있도록 하여 장을 편안하게 유지할 수 있다.In addition, the senna lobe or cenosides A & B may occur in some cases in the intestine, but in the present invention, intake of bakbak at 0.4 to 26 mg, which is about half of the daily intake of cenosides A & B. It can help you keep your bowels comfortable.
한편, 상기 센나엽 또는 세노사이드 A & B를 다량 복용할 경우에는 칼륨의 흡수억제로 인해, 칼륨 부족 현상이 올 수 있다는 종래 의약품 보고에 따라 칼륨을 함께 사용할 수도 있다. 따라서, 본 발명에 따른 건강 보조 식품 조성물은 칼륨 성분을 추가 포함할 수 있다. 첨가될 수 있는 칼륨성분의 함량은 함께 첨가되는 세노사이드 A & B의 함량에 대해 대등한 중량비로 포함되는 것이 바람직하거나, 인체에 필요한 하루 소비량의 5g 내에서 일상적으로 다른 섭식 양태를 용인하는 상태에서 첨가되는 것을 우선시 하고자 한다.On the other hand, when taking a large amount of the senna lobe or senoside A & B, potassium may be used together according to the conventional medicine report that potassium deficiency may occur due to inhibition of absorption of potassium. Thus, the dietary supplement composition according to the present invention may further comprise a potassium component. The content of the potassium component that can be added is preferably included in a weight ratio equivalent to the content of cenosides A & B added together, or in a state that tolerates other eating modes routinely within 5 g of the daily consumption required by the human body. Priority will be given to addition.
이러한 본 발명에 따른 장기능 활성효과를 갖는 건강 보조 식품 조성물은 과자류, 캔디류, 껌류 및 제과류의 건조 식품이며, 특히 과자류, 껌류에 적용가능하다.The dietary supplement composition having the intestinal activating effect according to the present invention is a dry food of confectionery, candy, gum and confectionery, and is particularly applicable to confectionery and gum.
또한, 본 발명에 따른 장기능 활성효과를 갖는 건강 보조 식품 조성물은 음용차류, 드링크제 및 유제품류의 습윤 식품일 수 있다.In addition, the dietary supplement composition having an enteric function activating effect according to the present invention may be a wet food of drinking tea, drink and dairy products.
하기 실시예를 통하여 본 발명을 좀더 구체적으로 살펴보지만, 이에 본 발명의 범주가 한정되는 것은 아니다.Although the present invention will be described in more detail with reference to the following examples, the scope of the present invention is not limited thereto.
실시예 1Example 1
어린 센나엽을 건조시킨 후, 미분세기로 평균직경 조립도 0.01mm이하의 크기로 분말화하여 총 사용원료량에 1g을 첨가하였고, 후박 1mg을 함께 첨가하여 과자를 제조하였다.After drying the young senna leaves, powdered powder with a mean diameter granulation degree of 0.01 mm or less was added to the fine powder, and 1 g was added to the total amount of raw materials, and 1 mg of groceries were added to prepare confectionery.
실시예 2Example 2
추출된 세노사이드 A & B를 건조시킨 후, 미분세기로 평균직경 조립도 0.01mm이하의 크기로 분말화하여 총 사용원료량에 1g을 첨가하였고, 후박 1mg을 함께 첨가하여 사탕을 제조하였다.The dried cenosides A & B were dried and then powdered to a size of 0.01 mm or less in average diameter granularity by differential strength, and 1 g was added to the total amount of raw material, and 1 mg of thick foil was added together to prepare candy.
실시예 3Example 3
어린 센나엽을 건조시킨 후, 미분세기로 평균직경 조립도 0.01mm이하의 크기로 분말화하여 총 사용원료량에 1g을 첨가하였고, 후박 1mg을 함께 첨가하여 껌을 제조하였다.After drying the young senna leaves, the powder was powdered to a size of less than 0.01mm in average diameter granularity by fine powder, and 1g was added to the total amount of raw materials, and gum was prepared by adding 1mg of groceries.
실시예 4Example 4
어린 센나엽을 물에 침출시킨 후, 그 침출용액을 그대로 사용하여 밀가루를 반죽할 때 첨가하여 빵을 제조하였다.After the young senna leaves were leached into water, the leaching solution was used as it was and added to knead flour to prepare bread.
실시예 5Example 5
추출된 세노사이드 A & B의 엑기스를 드링크제 제조시에 첨가하여 드링크제를 제조하였다.An extracted extract of cenosides A & B was added at the time of preparation of the drink to prepare a drink.
실시예 6Example 6
어린 센나엽을 에탄올에 침출시킨 후, 그 침출용액을 그대로 요구르트 제조시에 첨가하여 제조하였다.After the young senna leaves were leached in ethanol, the leaching solution was added as it is during yogurt production.
실시예 7Example 7
어린 센나엽을 건조시킨 후, 분세기로 평균직경 조립도 2mm이하의 크기로 분말화하여 총 사용원료량에 1g을 첨가하여 티백차를 제조하였다.After drying the young senna leaves, powdered to a size of less than 2mm average diameter granulation degree by centrifugation, 1g was added to the total amount of raw materials to prepare tea bags.
실시예 8Example 8
추출된 세노사이드 A & B를 건조시킨 후, 미분세기로 평균직경 조립도 0.01mm이하의 크기로 분말화하여 총 사용원료량에 1g을 첨가하였고, 후박 1mg을 함께 첨가하여 인스턴트 식품을 제조하였다.The dried cenosides A & B were dried, and then ground to a size of 0.01 mm or less in average diameter granularity by fine powder, 1g was added to the total amount of raw material, and 1 mg of thick foil was added to prepare instant food.
상기 실시예에 의해 제조된 식품을 갖고 20명의 임상실험 대상자를 통해 변비 개선 효과를 측정하였다.Constipation-improving effect was measured in 20 clinical subjects with the food prepared by the above example.
[임상실험대상자][Clinical subjects]
변비의 증상을 나타내어 장의 더부룩함,(하복부의 팽만감)을 호소하는 10대 및 40대의 남,여 20명20 men and women in their teens and 40s who have symptoms of constipation and complain of bloating of the intestines and bloating of the lower abdomen
1) 연령별 분포1) Distribution by age
10대-2명(10%), 20대-10명(50%), 30대-7명(35%), 40대-1명(5%)10s-2 (10%), 20s-10 (50%), 30s-7 (35%), 40s-1 (5%)
2) 성별 분포2) gender distribution
여성-18명(90%), 남성-2명(10%)18 females (90%), 2 males (10%)
3) 직업별 분포3) Distribution by occupation
고등학생(10%), 대학생(25%), 회사원(25%), 주부(20%), 전문직(5%),High school students (10%), college students (25%), office workers (25%), housewives (20%), professionals (5%),
자유직(5%), 공무원(5%), 기타(5%)Free employees (5%), civil servants (5%), others (5%)
[임상실험방법][Clinical Experiment Method]
상기 임상실험 대상자 20명에게 상기 실시예에 의해 제조된 식품을 복용하기 전과 후의 배변 횟수, 쾌변감, 변비 개선도 등을 측정하였다. 일반적인 배변의 개선이 느껴지기 시작한 일수를 측정하고 배변 횟수, 쾌변감, 개선도 등을 고려할 때 만족한 결과를 얻었다고 느끼는 날을 측정하였다.The 20 subjects were measured the number of bowel movements, comfort, constipation improvement and the like before and after taking the food prepared in Example. The number of days in which the improvement of general bowel movements began to be measured was measured, and the days on which feelings of satisfactory results were obtained in consideration of the number of bowel movements, comfort, and improvement were measured.
[임상실험][Clinical experiment]
1) 상기 실시예 1에 의해 제조된 과자를 하기 표 1에 기재된 대상자들에게 매일 동일량으로 섭취한 결과를 하기 표 1에 나타내었다.1) The result of ingesting the confectionery prepared in Example 1 in the same amount daily to the subjects listed in Table 1 is shown in Table 1 below.
2) 상기 실시예 2에 의해 제조된 사탕을 하기 표 2에 기재된 대상자들에게 매일 동일량으로 섭취한 결과를 하기 표 2에 나타내었다.2) The result of ingesting the candy prepared by Example 2 in the same amount daily to the subjects described in Table 2 is shown in Table 2 below.
3) 상기 실시예 3에 의해 제조된 껌을 하기 표 3에 기재된 대상자들에게 매일 동일량으로 섭취한 결과를 하기 표 3에 나타내었다.3) The result of ingesting the gum prepared by Example 3 in the same amount daily to the subjects described in Table 3 is shown in Table 3 below.
4) 상기 실시예 7에 의해 제조된 차를 하기 표 4에 기재된 대상자들에게 매일 동일량으로 섭취한 결과를 하기 표 4에 나타내었다.4) The results of ingesting the tea prepared in Example 7 in the same amount daily to the subjects described in Table 4 are shown in Table 4 below.
상기 임상실험을 통해 알 수 있는 바와 같이, 각 개인의 변비증상의 정도, 연령, 및 기타 주변 환경(식습관, 생활환경) 등에 따라 효과가 발생되는데 까지의 시간에 다소 개인차가 나타났지만, 모든 대상자들에 있어서 변비의 개선 효과가 나타남을 알 수 있다. 또한, 임상대상자들을 통해 확인한 결과, 심한 부작용을 느낀 경우가 극히 적음이 확인되었다.As can be seen from the above clinical trials, although individual differences appeared in the time until the effect occurs depending on the degree of constipation symptoms, age, and other surrounding environment (eating habits, living environment) of each individual, all subjects It can be seen that the improvement effect of constipation in. In addition, as a result of confirming through the clinical subjects, it was confirmed that very few cases of severe side effects.
상기 실시예 및 임상실험을 통해 알 수 있는 바와 같이, 본 발명에 따라 제조된 식품은 배변을 원활히 하도록 도와주며, 이와 함께 쾌변을 할 수 있게 함으로서 변비에 탁월한 효과를 나타내고, 이에 따라 다이어트에도 우수한 효과를 가짐을 알 수 있다.As can be seen from the above examples and clinical experiments, the food prepared according to the present invention helps to smooth bowel movements, and with this, it is an excellent effect on constipation by making it possible to have excitement, accordingly excellent effect on diet It can be seen that it has.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0011275A KR100429086B1 (en) | 2001-03-05 | 2001-03-05 | Health auxiliary food composition having effect for intestines function and food comprising same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0011275A KR100429086B1 (en) | 2001-03-05 | 2001-03-05 | Health auxiliary food composition having effect for intestines function and food comprising same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010044542A true KR20010044542A (en) | 2001-06-05 |
KR100429086B1 KR100429086B1 (en) | 2004-04-29 |
Family
ID=19706483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0011275A KR100429086B1 (en) | 2001-03-05 | 2001-03-05 | Health auxiliary food composition having effect for intestines function and food comprising same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100429086B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104757528A (en) * | 2014-01-06 | 2015-07-08 | 杨伦南 | Diabetes treating health food capsules |
KR101646156B1 (en) | 2014-09-29 | 2016-08-05 | 김구환 | Fermented foods improve bowel function and a method of manufactuing stercoral removal efficacy |
KR20230122692A (en) | 2022-02-15 | 2023-08-22 | 윤이수 | Manufacturing method kombucha enhanced palatability |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011687B2 (en) * | 1977-09-12 | 1985-03-27 | 武田薬品工業株式会社 | Method for producing cathartic substances containing sennosides |
JPS57145812A (en) * | 1981-03-06 | 1982-09-09 | Chugai Pharmaceut Co Ltd | Drug for constipation |
US4595592A (en) * | 1984-03-21 | 1986-06-17 | Dr. Madaus & Co. | Process for obtaining laxative compounds from senna drugs |
JPH04154728A (en) * | 1990-10-16 | 1992-05-27 | Keijiyun Go | Cathartic |
US5674522A (en) * | 1993-10-07 | 1997-10-07 | Mcneil-Ppc, Inc. | Beverage concentrate for drug delivery |
JP4022300B2 (en) * | 1997-12-18 | 2007-12-12 | 株式会社大塚製薬工場 | Laxative composition |
JP2000041625A (en) * | 1998-07-31 | 2000-02-15 | Shiseido Co Ltd | Edible composition |
JP3364453B2 (en) * | 1999-08-18 | 2003-01-08 | 大正薬品工業株式会社 | Sennoside-containing aqueous solution |
-
2001
- 2001-03-05 KR KR10-2001-0011275A patent/KR100429086B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100429086B1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100645385B1 (en) | Composition for anti-obesity | |
CN110447902B (en) | Composition with weight-losing effect | |
CN104026204A (en) | Edible traditional Chinese medicine food cookies and making method and purpose thereof | |
CN112245443A (en) | Composition of ginsenoside Rg3 and Rg5 and its anti-tumor medicine | |
CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
KR20190088740A (en) | Antioxidant and anti-Obesity composition comprising Psyllium Husk and Kaempferia parviflora, formulatiom using the composition and preparing method thereof | |
CN106173450A (en) | Improve compound feed additive and the feedstuff of pigeon immunity | |
KR100376307B1 (en) | Healthy food composition for preventing and treatmenting constipation | |
KR20050036928A (en) | A health care composition for treating or preventing intestinal disease and constipation | |
KR100429086B1 (en) | Health auxiliary food composition having effect for intestines function and food comprising same | |
CN101396419A (en) | Medicine composition for preventing the birth defect and improving the memory | |
CN110269251A (en) | Composition for relaxing bowels and promoting defecation and preparation method thereof | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
CN108245531B (en) | Composition for improving gastrointestinal tract function and preventing and treating constipation | |
CN1315411C (en) | Health-care food with functions of relaxing the bowels and beautifying, and its prepn. method | |
Mahboubi | Prunus domestica as effective and acceptable treatment for stool softening and relief of constipation symptoms. | |
KR100506824B1 (en) | Crude Drug Compositions for treating or preventing intestinal disease and constipation | |
WO2014134833A1 (en) | Edible composition, preparation method therefor, and food product comprising the composition | |
CN101264140A (en) | Medicinal composition for preventing birth defect and improving memory and intelligence | |
KR100450055B1 (en) | Food composition for improving physical constitution containing seeds of bean plants as main components, and food produced therefrom | |
CN110720527A (en) | Traditional Chinese medicine weight-losing tea | |
CN104587304A (en) | Medicine for treating simple obesity and application of medicine | |
CN102579713B (en) | Traditional Chinese medicine for treating children obesity and preparation method | |
CN108904596A (en) | It is a kind of to have effects that improve the composition of memory | |
KR20040024008A (en) | Health food composition for improving constipation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130415 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140418 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150615 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |